BRANCHBURG, N.J., July 10 /PRNewswire-FirstCall/ -- LifeCell Corporation , today announced plans to release second quarter 2007 operating results on Wednesday, July 25, 2007 at 8:00 a.m. Eastern. Paul Thomas, President and Chief Executive Officer, will host a conference call at 10:00 a.m. Eastern, to discuss the Company’s second quarter 2007 financial results.
The dial-in number for the live call is (800)289-0533 /domestic or (913)981-5525/international. A simultaneous webcast of the call will be available via LifeCell’s website at http://www.lifecell.com Corporate Information -- Investor Relations. The call will be archived on the Company’s website for at least 90 days.
A recording of the live-call will be available through July 31, 2007. The dial-in number to listen to the recording is (888) 203-1112 or (719) 457-0820. The replay access code is 7314136.
About LifeCell
LifeCell develops and markets innovative tissue repair products for use in reconstructive, orthopedic and urogynecologic surgical procedures. LifeCell’s current marketed products include: AlloDerm(R) for plastic reconstructive, general surgical, burn and periodontal procedures; Cymetra(R), a particulate form of AlloDerm(R) suitable for injection; GraftJacket(R) for orthopedic applications and lower extremity wounds; AlloCraft(TM)DBM, for bone grafting procedures; and Repliform(R) for urogynecologic surgical procedures. The Company’s research and development initiatives include programs focused on extending the use of its regenerative tissue matrix products into new surgical applications, as well as leveraging its core technology to other tissues, including non-human tissues, and expanding its product line in the rapidly growing biosurgery market. LifeCell maintains a website at http://www.lifecell.com.
LifeCell Corporation
CONTACT: Steven T. Sobieski, Chief Financial Officer of LifeCell,+1-908-947-1106, ssobieski@lifecell.com; or Kevin McGrath of CameronAssociates, +1-212-245-8800, kevin@cameronassoc.com
Web site: http://www.lifecell.com/
